Vanda Pharmaceuticals
VNDA
#8337
Rank
โ‚ฌ0.26 B
Marketcap
4,42ย โ‚ฌ
Share price
-1.54%
Change (1 day)
20.41%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ0.13 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ0.13 B21.79%
2024-12-31โ‚ฌ0.11 B20.73%
2023-12-31โ‚ฌ93.65 M-6.16%
2022-12-31โ‚ฌ99.79 M27.18%
2021-12-31โ‚ฌ78.46 M20.36%
2020-12-31โ‚ฌ65.19 M0.32%
2019-12-31โ‚ฌ64.98 M31.11%
2018-12-31โ‚ฌ49.57 M-19.67%
2017-12-31โ‚ฌ61.7 M-17.89%
2016-12-31โ‚ฌ75.14 M2.68%
2015-12-31โ‚ฌ73.18 M717.59%
2014-12-31โ‚ฌ8.95 M-87.54%
2013-12-31โ‚ฌ71.84 M-24.3%
2012-12-31โ‚ฌ94.9 M-17.36%
2011-12-31โ‚ฌ0.11 B-12.89%
2010-12-31โ‚ฌ0.13 B-6.8%
2009-12-31โ‚ฌ0.14 B4953.51%
2008-12-31โ‚ฌ2.79 M-68.87%
2007-12-31โ‚ฌ8.99 M24.87%
2006-12-31โ‚ฌ7.2 M67.69%
2005-12-31โ‚ฌ4.29 M222.13%
2004-12-31โ‚ฌ1.33 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ103.84 B 78,263.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ69.05 B 52,011.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ101.68 B 76,630.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ74.06 B 55,790.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ71.78 B 54,072.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ57.57 B 43,349.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
โ‚ฌ0.22 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA